We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Herpes Link May Lead to CFS Test

By HospiMedica staff writers
Posted on 29 Mar 2005
Some cases of chronic fatigue syndrome (CFS) may be linked to human herpesvirus 6A variant (HHV-6A), according to the HHV-6 Foundation (Santa Barbara, CA, USA). More...
This and other recent findings may lead to a test for the disease.

The HHV-6 virus was discovered in the late 1980s. While the B variant is very common, appearing in more than 96% of the population, the A variant is less common. The A variant has been linked to CFS and multiple sclerosis (MS) and may hasten the progression of HIV. According to Dr. Dharam Ablashi, co-discoverer of the virus and scientific director of the HHV-6 Foundation, there is a strong association between HHV-6 and CFS when the correct testing method is used.

The HHV-6 virus is difficult to find, which helps to explain why it took so long to identify the link to CFS. "The virus is neurotropic, meaning it prefers to live in the brain tissue,” explained Dr. Ablashi. "It is quite possible to find a significant infection in the brain tissue, but no virus in the serum by DNA testing.”

"Our primary objective at the moment is to get a test on the market that will be a sensitive indicator of active infection,” observed Kristin Loomis, executive director of HHV-6 Foundation. "The evidence presented at the conference will go a long way toward dispelling the notion, still held by some physicians, that CFS is purely psychiatric.”

Dr. Daniel Petersen, a leading CFS clinician from Sierra Internal Medicine (Nevada, UT, USA), has performed spinal taps on patients with abnormal magnetic resonance imaging (MRI) or severe problems with cognitive functioning. He found active HHV-6A virus in the spinal fluid of 20% of those patients. He has been treating some of his most severe cases with intravenous antiviral therapy and the majority have responded. Dr. Petersen does not tell them they have CFS; he tells them they have HHV-6A subacute encephalopathy.




Related Links:
HHV-6 Foundation

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gynecological Examination Chair
arco-matic
Cardiograph Device
PageWriter TC35
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.